194 related articles for article (PubMed ID: 2202586)
1. Efficacies of chloroquine and pyrimethamine-sulphadoxine in a Nigerian population with chloroquine resistant P. falciparum malaria.
Usanga EA; Ezedinachi EN; Gemade EI; Ikpatt NW; Alaribe AA
East Afr Med J; 1990 May; 67(5):295-301. PubMed ID: 2202586
[TBL] [Abstract][Full Text] [Related]
2. Efficacies of chloroquine, pyrimethamine/sulphadoxine and pyrimethamine/sulphalene against P. falciparum in northeastern Nigeria.
Molta NB; Daniel HI; Watila IM; Oguche SO; Otu TI; Ameh JO; Gadzama NM
J Trop Med Hyg; 1992 Aug; 95(4):253-9. PubMed ID: 1495121
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
Fadeke Aderounmu A; Salako LA; Laoye AJ; Modupe Makinde J; Aina Adio R
Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365
[TBL] [Abstract][Full Text] [Related]
4. Response of falciparum malaria to chloroquine and three second line antimalarial drugs in a Kenyan coastal school age population.
Hagos B; Khan B; Ofulla AV; Kariuki D; Martin SK
East Afr Med J; 1993 Oct; 70(10):620-3. PubMed ID: 8187656
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in Nigerian children.
Ekanem OJ; Weisfeld JS; Salako LA; Nahlen BL; Ezedinachi EN; Walker O; Breman JG; Laoye OJ; Hedberg K
Bull World Health Organ; 1990; 68(1):45-52. PubMed ID: 2189585
[TBL] [Abstract][Full Text] [Related]
6. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
[TBL] [Abstract][Full Text] [Related]
7. [Monitoring the chemoresistance of Plasmodium falciparum malaria in Yopougon (Abidjan): in vivo study of chloroquine sensitivity and evaluation of pyrimethamine resistance following the analysis of point mutation in the dihydrofolate reductase gene].
Djaman AJ; Basco LK; Mazabraud A
Sante; 2002; 12(4):363-7. PubMed ID: 12626289
[TBL] [Abstract][Full Text] [Related]
8. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of chloroquine (CQ) and sulphadoxine/pyrimethamine (SP) therapy in uncomplicated falciparum malaria in Indo-Myanmar border areas.
Mohapatra PK; Prakash A; Taison K; Negmu K; Gohain AC; Namchoom NS; Wange D; Bhattacharyya DR; Goswami BK; Borgohain BK; Mahanta J
Trop Med Int Health; 2005 May; 10(5):478-83. PubMed ID: 15860095
[TBL] [Abstract][Full Text] [Related]
10. Chloroquine versus pyrimethamine/sulphadoxine in the treatment of uncomplicated P. falciparum malaria in northern Kenya.
Falaschi F; Ansaloni L
East Afr Med J; 1997 May; 74(5):275-7. PubMed ID: 9337001
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Sulphadoxine and Pyrimethamine, Doxycycline and their combination in the treatment of chloroquine resistant Falciparum Malaria.
Elkheir HK; Elkarim EF; Eltayeb IB; Elkadaru AE; Babiker HA; Ibrahim AM
Saudi Med J; 2001 Aug; 22(8):690-3. PubMed ID: 11573114
[TBL] [Abstract][Full Text] [Related]
12. Effect of four different types of single-dose treatment with chloroquine and with chloroquine and pyrimethamine on Plasmodium falciparum infections in a semi-immune population in northern Nigeria.
Kusnecov R; Storey J; Lietaert P
Bull World Health Organ; 1972; 46(1):117-22. PubMed ID: 4555036
[TBL] [Abstract][Full Text] [Related]
13. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
Djaman J; Abouanou S; Basco L; Koné M
Sante; 2004; 14(4):205-9. PubMed ID: 15745869
[TBL] [Abstract][Full Text] [Related]
14. Open randomized study of pyrimethamine-sulphadoxine vs. pyrimethamine-sulphadoxine plus probenecid for the treatment of uncomplicated Plasmodium falciparum malaria in children.
Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Falade CO; Tambo E; Fateye BA; Happi TC; Oduola AM
Trop Med Int Health; 2004 May; 9(5):606-14. PubMed ID: 15117306
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of malaria prophylaxis in peninsular Malaysia using chloroquine and a combination of sulphadoxine and pyrimethamine.
Ponnampalam JT
J Trop Med Hyg; 1978 Oct; 81(10):198-203. PubMed ID: 366165
[No Abstract] [Full Text] [Related]
16. In vivo efficacy of chloroquine, halofantrine, pyrimethamine-sulfadoxine and qinghaosu (artesunate) in the treatment of malaria in Calabar, Nigeria.
Ezedinachi E
Cent Afr J Med; 1996 Apr; 42(4):109-11. PubMed ID: 8791866
[TBL] [Abstract][Full Text] [Related]
17. Chloroquine-resistant falciparum malaria in an area of rising endemicity in Zimbabwe.
Mharakurwa S; Mugochi T
J Trop Med Hyg; 1994 Feb; 97(1):39-45. PubMed ID: 8107172
[TBL] [Abstract][Full Text] [Related]
18. Short report: comparison of chlorproguanil-dapsone with a combination of sulfadoxine-pyrimethamine and chloroquine in children with malaria in northcentral Nigeria.
Ogunfowokan O; Dankyau M; Madaki AJ; Thacher TD
Am J Trop Med Hyg; 2009 Feb; 80(2):199-201. PubMed ID: 19190213
[TBL] [Abstract][Full Text] [Related]
19. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
